DE602004014974D1 - Verwendung von zusammensetzungen mit oleansäure und ursolsäure zur herstellung eines medikaments zur behandlung von überempfindlichkeit und hyperreaktivität - Google Patents
Verwendung von zusammensetzungen mit oleansäure und ursolsäure zur herstellung eines medikaments zur behandlung von überempfindlichkeit und hyperreaktivitätInfo
- Publication number
- DE602004014974D1 DE602004014974D1 DE602004014974T DE602004014974T DE602004014974D1 DE 602004014974 D1 DE602004014974 D1 DE 602004014974D1 DE 602004014974 T DE602004014974 T DE 602004014974T DE 602004014974 T DE602004014974 T DE 602004014974T DE 602004014974 D1 DE602004014974 D1 DE 602004014974D1
- Authority
- DE
- Germany
- Prior art keywords
- acid
- hyperreactivity
- medicament
- preparation
- composites
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03258087 | 2003-12-19 | ||
PCT/GB2004/005453 WO2005058302A1 (en) | 2003-12-19 | 2004-12-17 | Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004014974D1 true DE602004014974D1 (de) | 2008-08-21 |
Family
ID=34684630
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004014974T Active DE602004014974D1 (de) | 2003-12-19 | 2004-12-17 | Verwendung von zusammensetzungen mit oleansäure und ursolsäure zur herstellung eines medikaments zur behandlung von überempfindlichkeit und hyperreaktivität |
Country Status (9)
Country | Link |
---|---|
US (1) | US20110229563A1 (de) |
EP (1) | EP1694320B1 (de) |
JP (1) | JP2007514727A (de) |
CN (1) | CN1893937B (de) |
AT (1) | ATE400262T1 (de) |
DE (1) | DE602004014974D1 (de) |
ES (1) | ES2311177T3 (de) |
PL (1) | PL1694320T3 (de) |
WO (1) | WO2005058302A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103429251B (zh) * | 2010-11-22 | 2017-09-15 | 菲尼克斯生物技术公司 | 用夹竹桃属物种或黄花夹竹桃属物种的提取物治疗神经病症的方法 |
ES2936634T3 (es) | 2013-02-08 | 2023-03-21 | Gen Mills Inc | Productos alimenticios reducidos en sodio |
KR101645963B1 (ko) * | 2014-05-13 | 2016-08-08 | 주식회사한국야쿠르트 | 사과박(apple pomace)으로부터 우르솔릭산을 고효율로 추출하는 방법 및 그 방법에 의해 추출된 우르솔릭산을 유효성분으로 함유하는 식품조성물 |
CN104610417B (zh) * | 2015-02-16 | 2016-05-11 | 白心亮 | 一种从山楂中提取熊果酸和齐墩果酸的方法 |
MX2020002884A (es) * | 2017-09-14 | 2020-10-05 | Phoenix Biotechnology Inc | Método y composición neuroprotectora mejorada para tratar afecciones neurológicas. |
DE102018217341A1 (de) * | 2018-10-10 | 2020-04-16 | Katjes Fassin GmbH.+Co. Kommanditgesellschaft | Mit apfelwachs beschichtetes bonbon |
JP7276745B2 (ja) * | 2019-06-14 | 2023-05-18 | 地方独立行政法人青森県産業技術センター | リンゴ由来トリテルペノイド含有組成物製造方法、ウルソール酸製造方法、およびオレアノール酸製造方法 |
CN112704663B (zh) * | 2020-12-18 | 2022-07-19 | 吉林农业科技学院 | 一种枇杷叶熊果酸乳膏的制备方法 |
CN114129572B (zh) * | 2021-12-16 | 2023-04-07 | 南开大学 | 一种协同抑制汉防己甲素诱导的药源性肝损伤的药物组合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03287530A (ja) * | 1990-03-31 | 1991-12-18 | Snow Brand Milk Prod Co Ltd | 免疫抑制剤 |
JPH1112178A (ja) * | 1997-06-23 | 1999-01-19 | Dainippon Pharmaceut Co Ltd | オレアノール酸系抗掻痒剤 |
ATE308892T1 (de) * | 2000-06-05 | 2005-11-15 | Loders Croklaan Bv | Ursolsäure und oleanolsäure enthaltende mischungen |
ATE295087T1 (de) * | 2001-04-09 | 2005-05-15 | Loders Croklaan Bv | Konzentrat von triterpenen |
JP5081354B2 (ja) * | 2001-11-07 | 2012-11-28 | 株式会社ナリス化粧品 | IgE産生抑制剤 |
-
2004
- 2004-12-17 AT AT04806247T patent/ATE400262T1/de not_active IP Right Cessation
- 2004-12-17 ES ES04806247T patent/ES2311177T3/es active Active
- 2004-12-17 DE DE602004014974T patent/DE602004014974D1/de active Active
- 2004-12-17 US US10/583,151 patent/US20110229563A1/en not_active Abandoned
- 2004-12-17 WO PCT/GB2004/005453 patent/WO2005058302A1/en active IP Right Grant
- 2004-12-17 CN CN2004800379582A patent/CN1893937B/zh not_active Expired - Fee Related
- 2004-12-17 PL PL04806247T patent/PL1694320T3/pl unknown
- 2004-12-17 EP EP04806247A patent/EP1694320B1/de not_active Not-in-force
- 2004-12-17 JP JP2006544564A patent/JP2007514727A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2005058302A1 (en) | 2005-06-30 |
EP1694320B1 (de) | 2008-07-09 |
US20110229563A1 (en) | 2011-09-22 |
ES2311177T3 (es) | 2009-02-01 |
ATE400262T1 (de) | 2008-07-15 |
EP1694320A1 (de) | 2006-08-30 |
CN1893937A (zh) | 2007-01-10 |
PL1694320T3 (pl) | 2008-11-28 |
JP2007514727A (ja) | 2007-06-07 |
CN1893937B (zh) | 2011-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sharma et al. | Effect of denture cleansers on surface roughness and flexural strength of heat cure denture base resin-an in vitro study | |
DE602005019319D1 (de) | Zusammensetzungen mit ornithin und phenylacetat oder phenylbutyrat zur behandlung von hepatischer enzephalopathie | |
ATE390142T1 (de) | Synergistische zusammensetzung zur behandlung von diabetes mellitus | |
DE60118723D1 (de) | Verwendung von azetogenischen hydrogenotrophischen stämmen zur vorbeugung und behandlung von verdauungskrankheiten | |
AR049955A1 (es) | Composiciones y metodos para el tratamiento de trastornos metabolicos | |
ATE444738T1 (de) | Verbesserte essbare filmformulierungen mit maltodextrin | |
IS8395A (is) | Fjölvasýklískar karboxýlsýrur og asýlsúlfónamíð sem hindrar á lifrabólgu C eftirmyndun | |
ATE318133T1 (de) | Verwendung von stearidonsäure zur herstellung eines arzneimittels für die behandlung oder vorbeugung von krebs | |
DE602004014974D1 (de) | Verwendung von zusammensetzungen mit oleansäure und ursolsäure zur herstellung eines medikaments zur behandlung von überempfindlichkeit und hyperreaktivität | |
ZA202210079B (en) | Compositions and methods for treating or preventing inflammatory diseases including diabetes mellitus 10 type i and type ii and thyroid diseases | |
ATE468849T1 (de) | Idebenon zur behandlung von muskeldystrophien | |
Wu et al. | The protective effects of resveratrol, H2S and thermotherapy on the cell apoptosis induced by CdTe quantum dots | |
DE69803773D1 (de) | Yohimbine und arginin enthaltende zusammensetzung zur behandlung der erektilen fehlfunktion | |
Alaghehmad et al. | Effect of 0.12% chlorhexidine and zinc nanoparticles on the microshear bond strength of dentin with a fifth-generation adhesive | |
ATE547120T1 (de) | VERFAHREN ZUM EINKAPSELN VON ORAL AUFGENOMMENEN MATERIALIEN ZUR VERÄNDERUNG DES VERDAUUNGSORTES; DES WIRKORTES ODER DER STABILITÄTß | |
DE602004005455D1 (de) | Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin | |
DE602006020838D1 (de) | Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum | |
DE60206280D1 (de) | Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia | |
DE602004012984D1 (de) | Verwendung eines lupinkonglutins für die behandlung von diabetes typ ii | |
DE602004027923D1 (de) | Zusammensetzung mit notoginseng radix extrakt zur prävention und behandlung von arthritis als wirksamer inhaltsstoff | |
WO2006128179A3 (en) | Use of matrilin-1 for the treatment of angiogenesis related diseases | |
PH12021551011A1 (en) | Compositions and methods for treating transient biofilms | |
ATE386513T1 (de) | Verwendung von angelicin und seiner strukturellen analoga zur behandlung von thalassämie | |
DE69930624D1 (de) | Arzneimittel für hinterstrangataxie und zusammensetzung zur behandlung von hinterstrangataxie | |
ATE193206T1 (de) | Zusammensetzung zur behandlung oder vorbeugung von herpes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |